WithdrawnNCT00458445
This study exists to explore whether the medication SPD465 could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 19 Years to 25 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT04167189
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
ADHDOtherFrom 7 Years to 49 Years
- Countries
- United States
- Sponsor
- PhenoSolve, LLC
- Condition
- ADHD
CompletedNCT03247530
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 11 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT01244490
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Austria, Canada, France, Germany, Ireland, Italy, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03247556
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
ADHDOtherFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT03292952
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Zevra Therapeutics
- Condition
- ADHD
CompletedNCT02255513
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Condition
- ADHD
CompletedNCT01081132
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03446885
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
ADHDOtherFrom 16 Years to 25 Years
- Countries
- United States
- Sponsor
- Gregory Fabiano
- Condition
- ADHD
CompletedNCT00202605
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00877487
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03247517
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPN-812 in practice and what may need to be adjusted.
ADHDOtherFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT00735371
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00764868
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01010750
This study exists to explore whether this type of care could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00367835
This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00734578
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00500149
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01081145
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01106430
This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Belgium, Canada, Germany, Hungary, Italy, Poland, Spain, Sweden, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01552902
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 13 Years to 17 Years
- Countries
- Canada, Germany, Hungary, Sweden, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01101022
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00697515
This study exists to compare options and see whether the medication Lisdexamfetamine offers something meaningfully different. Researchers are trying to understand what the medication Lisdexamfetamine could change in day-to-day care and decision-making.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00784654
This study exists to understand how the medication LDX holds up over time after the earliest research stage. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Belgium, France, Germany, Hungary, Italy, Poland, Sweden, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT02402166
This study exists to understand whether the medication SPD489 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication SPD489 in practice and what may need to be adjusted.
ADHDOtherFrom 4 Years to 5 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD